Published online April 1, 2008
PEDIATRICS Vol. 121 No. 4 April 2008, pp. 777-782 (doi:10.1542/peds.2007-0730)

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services E-mail this article to a friend Similar articles in this journal Similar articles in Web of Science Similar articles in PubMed Alert me to new issues of the journal Add to My File Cabinet Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via CrossRef Citing Articles via Web of Science (11) Citing Articles via Google Scholar Google Scholar Articles by Pashankar, F. D. Articles by Friedman, A. Search for Related Content PubMed PubMed Citation Articles by Pashankar, F. D. Articles by Friedman, A. Related Collections Blood Social Bookmarking                         What's this?

ARTICLE

Prevalence and Risk Factors of Elevated Pulmonary Artery Pressures in Children With Sickle Cell Disease

Farzana D. Pashankar, MD, Judith Carbonella, APRN, Alia Bazzy-Asaad, MD and Alan Friedman, MD

Department of Pediatrics, Yale University School of Medicine, New Haven, Connecticut

OBJECTIVES. The objectives of this study were (1) to determine the prevalence and risk factors of elevated pulmonary artery pressures in children with homozygous SS or Sβ° thalassemia using Doppler echocardiography and (2) to determine a correlation between abnormal transcranial Doppler examinations and elevated pulmonary artery pressures.

METHODS. Screening echocardiograms were prospectively performed during an annual comprehensive clinic visit on children who were older than 6 years and had homozygous SS or Sβ° thalassemia. Detailed history, examination, and laboratory tests were done, and transcranial Doppler examinations were obtained in children 2 to 14 years of age. Pulmonary hypertension was defined as pulmonary artery systolic pressure of at least 30 mmHg corresponding to a peak tricuspid regurgitant jet velocity of 2.5 m/second. Mild pulmonary hypertension was defined as tricuspid regurgitant jet velocity 2.5 to 2.9 m/second. Moderate pulmonary hypertension was defined as tricuspid regurgitant jet velocity 3 m/second. Patients with pulmonary stenosis or right outflow obstruction were excluded. Characteristics were compared between patients with mild, moderate, and no pulmonary hypertension using 1-way analysis of variance for continuous variable and Fisher's exact test for categorical variables.

RESULTS. Of the 75 patients who had homozygous SS/Sβ° thalassemia and were older than 6 years, echocardiograms were obtained for 62 (82.6%). Thirty percent (19 of 62) of patients had elevated tricuspid regurgitant jet velocity 2.5 m/second. One third of these patients had tricuspid regurgitant jet velocity 3 m/second. All patients with elevated tricuspid regurgitant jet velocity had SS disease. A high reticulocyte count, low oxygen saturation, and a high platelet count were significantly associated with elevated pulmonary artery pressures. There was no difference in age, gender, history of acute chest syndrome, hydroxyurea therapy, chronic blood transfusion, stroke, hemoglobin, and bilirubin between patients with and without elevated pulmonary artery pressures. A total of 47% patients with elevated tricuspid regurgitant jet velocity and 57% without elevated tricuspid regurgitant jet velocity had screening transcranial Doppler examinations. Transcranial Doppler examinations were normal for all patients.

CONCLUSIONS. High pulmonary artery pressures do occur in children with sickle cell disease. Screening by echocardiography can lead to early detection and intervention that may potentially reverse this disease process. There was no correlation between elevated pulmonary artery pressures and abnormal transcranial Doppler examination in our study.

---

Key Words: sickle cell disease • pulmonary hypertension • hypoxemia

Abbreviations: PHT—pulmonary hypertension • TRV—tricuspid regurgitant jet velocity • TCD—transcranial Doppler • LDH—lactate dehydrogenase

---

Accepted Aug 27, 2007.

CiteULike    Connotea    Del.icio.us    Digg    Facebook    Reddit    Technorati    Twitter    What's this?

This article has been cited by other articles:

				I M Balfour-Lynn, D J Field, P Gringras, B Hicks, E Jardine, R C Jones, A G Magee, R A Primhak, M P Samuels, N J Shaw, et al. BTS guidelines for home oxygen in children Thorax, August 1, 2009; 64(Suppl_2): ii1 - ii26. [Full Text] [PDF]

				K. L. Wallace, M. A. Marshall, S. I. Ramos, J. A. Lannigan, J. J. Field, R. M. Strieter, and J. Linden NKT cells mediate pulmonary inflammation and dysfunction in murine sickle cell disease through production of IFN-{gamma} and CXCR3 chemokines Blood, July 16, 2009; 114(3): 667 - 676. [Abstract] [Full Text] [PDF]

				C. P. Minniti, C. Sable, A. Campbell, S. Rana, G. Ensing, N. Dham, O. Onyekwere, M. Nouraie, G. J. Kato, M. T. Gladwin, et al. Elevated tricuspid regurgitant jet velocity in children and adolescents with sickle cell disease: association with hemolysis and hemoglobin oxygen desaturation Haematologica, March 1, 2009; 94(3): 340 - 347. [Abstract] [Full Text] [PDF]

				M. T. Gladwin and E. Vichinsky Pulmonary Complications of Sickle Cell Disease N. Engl. J. Med., November 20, 2008; 359(21): 2254 - 2265. [Full Text] [PDF]

				C. R. Morris Mechanisms of Vasculopathy in Sickle Cell Disease and Thalassemia Hematology, January 1, 2008; 2008(1): 177 - 185. [Abstract] [Full Text] [PDF]